Clorox (CLX) Cash from Financing Activities (2009 - 2026)

Clorox's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 476.59% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $578.0 million, a 162.96% increase from a year earlier, with the FY2025 full-year figure at -$924.0 million, down 41.07% from the prior year.
• Cash from Financing Activities improved to $1.1 billion in Q1 2026 per CLX's latest filing, from -$210.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.1 billion in Q1 2026 and bottomed at -$326.0 million in Q2 2022.
• The 5-year median for Cash from Financing Activities is -$227.0 million (2023), against an average of -$113.5 million.
• Across the five-year window, Cash from Financing Activities soared 542.86% in 2023 and slumped 252.9% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$280.0 million in 2022, then increased by 7.5% to -$259.0 million in 2023, then surged by 57.92% to -$109.0 million in 2024, then slumped by 92.66% to -$210.0 million in 2025, then soared by 636.19% to $1.1 billion in 2026.
• Per Business Quant, the three latest CLX Cash from Financing Activities figures stand at $1.1 billion (Q1 2026), -$210.0 million (Q4 2025), and -$59.0 million (Q3 2025).